{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:27:52Z","timestamp":1758058072573,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01 DA023659","K05 DA00343","T32 DA015036"],"award-info":[{"award-number":["K01 DA023659","K05 DA00343","T32 DA015036"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.ejphar.2008.09.011","type":"journal-article","created":{"date-parts":[[2008,9,23]],"date-time":"2008-09-23T04:23:43Z","timestamp":1222143823000},"page":"64-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A therapeutic dose of zolpidem has limited abuse-like effects in drug-na\u00efve females: A pilot study"],"prefix":"10.1016","volume":"598","author":[{"given":"Stephanie C.","family":"Licata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Penetar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Dunlap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott E.","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.09.011_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0013-7006(04)95426-7","article-title":"Dependence on zolpidem: a report of two cases","volume":"30","author":"Boulanger-Rostowsky","year":"2004","journal-title":"Encephale"},{"key":"10.1016\/j.ejphar.2008.09.011_bib2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2125.2007.03028.x","article-title":"Zolpidem abuse, dependence and withdrawal syndrome: sex as susceptibility factor for adverse effects","volume":"65","author":"Cuba\u0142a","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.09.011_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1099-1557(199905\/06)8:3<207::AID-PDS421>3.0.CO;2-1","article-title":"Prescribed daily doses and \u2018risk factors\u2019 associated with the use of benzodiazepines in primary care","volume":"8","author":"de las Cuevas","year":"1999","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ejphar.2008.09.011_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0376-8716(84)90030-9","article-title":"Reinforcing properties of lorazepam in normal volunteer subjects","volume":"13","author":"de Wit","year":"1984","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2008.09.011_bib5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0091-3057(84)80066-0","article-title":"Lack of preference for flurazepam in normal volunteers","volume":"21","author":"de Wit","year":"1984","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2008.09.011_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF00431805","article-title":"Drug preference in normal volunteers: effects of age and time of day","volume":"87","author":"de Wit","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2008.09.011_bib7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF00445569","article-title":"Assessing pentobarbital preference in normal volunteers using a cumulative dosing procedure","volume":"99","author":"de Wit","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2008.09.011_bib8","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0022-3565(25)23193-7","article-title":"Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability","volume":"255","author":"Evans","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.09.011_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00008877-199503000-00010","article-title":"Behavioral and subjective effects of DN-2327 (pazinaclone) and alprazolam in normal volunteers","volume":"6","author":"Evans","year":"1995","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.09.011_bib10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0009-9236(98)90139-4","article-title":"Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo","volume":"64","author":"Greenblatt","year":"1998","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2008.09.011_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050422","article-title":"Benzodiazepine self-administration in humans and laboratory animals \u2014 implications for problems of long-term use and abuse","volume":"134","author":"Griffiths","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2008.09.011_bib12","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0022-3565(25)11429-8","article-title":"Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal","volume":"260","author":"Griffiths","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.09.011_bib13","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0376-8716(03)00098-X","article-title":"Principles of initial experimental drug abuse liability assessment in humans","volume":"70","author":"Griffiths","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2008.09.011_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1360-0443.2003.00631.x","article-title":"A postmarketing study of relative abuse liability of hypnotic sedative drugs","volume":"99","author":"Jaffe","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.ejphar.2008.09.011_bib15","first-page":"197","article-title":"Assessment of the abuse potential of morphine-like drugs (methods used in man)","volume":"Vol. 45\/1","author":"Jasinski","year":"1977"},{"key":"10.1016\/j.ejphar.2008.09.011_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.mcp.0000245705.69440.6a","article-title":"Gender differences in sleep disorders","volume":"12","author":"Krishnan","year":"2006","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.ejphar.2008.09.011_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00003495-199040020-00008","article-title":"Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential","volume":"40","author":"Langtry","year":"1990","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2008.09.011_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/0269881103017001723","article-title":"Zolpidem dependence case series: possible neurological mechanisms and clinical management","volume":"17","author":"Liappas","year":"2003","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2008.09.011_bib19","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/jama.1992.03490120092034","article-title":"A critical appraisal of 98.6 degrees F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich","volume":"268","author":"Mackowiak","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2008.09.011_bib21","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.clinthera.2006.07.008","article-title":"Patient characteristics and patterns of drug use for sleep complaints in the United States: analysis of National Ambulatory Medical Survey Data, 1997\u20132002","volume":"28","author":"Morlock","year":"2006","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2008.09.011_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.0306-5251.2003.01852.x","article-title":"Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men","volume":"56","author":"Olubodun","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.09.011_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1037\/1064-1297.15.4.328","article-title":"Comparison of zolpidem and midazolam self-administration under progressive-ratio schedules: consumer demand and labor supply analyses","volume":"15","author":"Rowlett","year":"2007","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2008.09.011_bib24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1073\/pnas.0405621102","article-title":"Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates","volume":"102","author":"Rowlett","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2008.09.011_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hup.240","article-title":"Zolpidem and triazolam interact differentially with a delay interval on a digit-enter-and-recall task","volume":"16","author":"Rush","year":"2001","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2008.09.011_bib26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00004714-199604000-00007","article-title":"Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers","volume":"16","author":"Rush","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2008.09.011_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0022-3565(24)36361-X","article-title":"Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans","volume":"280","author":"Rush","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2008.09.011_bib28","doi-asserted-by":"crossref","first-page":"1540165","DOI":"10.1097\/00004714-199804000-00008","article-title":"Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects","volume":"18","author":"Rush","year":"1998","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2008.09.011_bib29","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s002130050997","article-title":"Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans","volume":"144","author":"Rush","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2008.09.011_bib30","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2165\/00003088-199529030-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of zolpidem","volume":"29","author":"Salva","year":"1995","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2008.09.011_bib31","first-page":"139","article-title":"Zolpidem at supratherapeutic doses can cause drug abuse, dependence, and withdrawal seizure","volume":"53","author":"Sethi","year":"2005","journal-title":"J. Assoc. Phys. India"},{"key":"10.1016\/j.ejphar.2008.09.011_bib32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-2000-11224","article-title":"Epidemiological evidence for a low abuse potential of zolpidem","volume":"33","author":"Soyka","year":"2000","journal-title":"Pharmacopsychiatry"},{"year":"2007","series-title":"Drug Abuse Warning Network, 2005: National Estimates of Drug-Related Emergency Department Visits","author":"Substance Abuse and Mental Health Services Administration, Office of Applied Studies","key":"10.1016\/j.ejphar.2008.09.011_bib33"},{"key":"10.1016\/j.ejphar.2008.09.011_bib34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00004714-200006000-00007","article-title":"Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance","volume":"20","author":"Troy","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2008.09.011_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0091-3057(97)00584-4","article-title":"The abuse potential of zolpidem administered alone and with alcohol","volume":"60","author":"Wilkinson","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2008.09.011_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0031-6997(25)00468-5","article-title":"Benzodiazepines: use, abuse, and consequences","volume":"44","author":"Woods","year":"1992","journal-title":"Pharmacol. Rev."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908009552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908009552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:10:00Z","timestamp":1757974200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908009552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":35,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0014299908009552"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.09.011","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A therapeutic dose of zolpidem has limited abuse-like effects in drug-na\u00efve females: A pilot study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}